Page last updated: 2024-09-03

ro 8-0576 and Anochlesia

ro 8-0576 has been researched along with Anochlesia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Himori, N; Mishima, K1
Akaike, N; Himori, N; Kurasawa, M; Mishima, K; Tanaka, Y1

Other Studies

2 other study(ies) available for ro 8-0576 and Anochlesia

ArticleYear
The COMT inhibitor tolcapone potentiates the anticataleptic effect of Madopar in MPP(+)-lesioned mice.
    Experientia, 1994, Oct-15, Volume: 50, Issue:10

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Benserazide; Benzophenones; Catalepsy; Catechol O-Methyltransferase Inhibitors; Drug Combinations; Drug Synergism; Haloperidol; Kinetics; Levodopa; Male; Mice; Mice, Inbred C57BL; Nitrophenols; Tolcapone; Tyrosine

1994
3-O-methyldopa attenuates the effects of Madopar on the haloperidol-induced cataleptic behavior and the locomotor activity in the mouse.
    Pharmacology, 1994, Volume: 48, Issue:4

    Topics: Animals; Benserazide; Catalepsy; Drug Combinations; Haloperidol; Levodopa; Male; Mice; Motor Activity; Tyrosine

1994